SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Iluka Resources Limited (ILKAY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 44/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ILKAY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.34
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.25
Book Value / Share$0.00
Revenue / Share$11.44
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-13.40 |
$726.3M |
$-224M |
-30.8% |
| 2017 |
$-10.25 |
$1.02B |
$-171.6M |
-16.9% |
| 2018 |
$17.95 |
$1.29B |
$303.9M |
23.5% |
| 2019 |
$-3.55 |
$1.23B |
$-279.9M |
-22.7% |
| 2020 |
$1.20 |
$990M |
$2.41B |
243.6% |
| 2021 |
$4.30 |
$1.56B |
$365.8M |
23.5% |
| 2022 |
$6.90 |
$1.61B |
$584.5M |
36.3% |
| 2023 |
$4.00 |
$1.29B |
$342.6M |
26.5% |
| 2024 |
$2.70 |
$1.17B |
$231.3M |
19.8% |
| 2025 |
$-3.25 |
$980.87M |
$-278.59M |
-28.4% |
